Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the FAERS database
- DOI
- 10.3389/fonc.2026.1836198
- Published
- 2026-07-27
- Container
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1836198,
title = {Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the FAERS database},
author = {Qian Zhang and Qinqin Feng and Shuang Lei and Wei Yang and Wanpeng Zhang and Xifeng Liu},
year = {2026},
journal = {Frontiers in Oncology},
doi = {10.3389/fonc.2026.1836198},
url = {https://doi.org/10.3389/fonc.2026.1836198}
}RIS
TY - JOUR TI - Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the FAERS database AU - Qian Zhang AU - Qinqin Feng AU - Shuang Lei AU - Wei Yang AU - Wanpeng Zhang AU - Xifeng Liu PY - 2026 JO - Frontiers in Oncology DO - 10.3389/fonc.2026.1836198 UR - https://doi.org/10.3389/fonc.2026.1836198 ER -
APA
Zhang, Q., Feng, Q., Lei, S., Yang, W., Zhang, W., & Liu, X. (2026). Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the FAERS database. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1836198
Source records
- crossref · retrieved 2026-09-25T12:27:23.936Z